This track will explore the latest research on cancer biomarkers, focusing on their role in early diagnosis and personalized treatment strategies. Discussions will include innovative methodologies for biomarker discovery and validation.

This session will highlight cutting-edge therapeutic approaches in oncology, including monoclonal antibodies and targeted therapies. Participants will examine the efficacy and safety of these treatments in various cancer types.

This track will address the ethical dilemmas faced in oncology, including end-of-life care and informed consent. Experts will discuss the implications of emerging technologies on patient autonomy and decision-making.

This session will focus on the latest advancements in surgical techniques for cancer treatment, including minimally invasive procedures and robotic surgery. The impact of these innovations on patient outcomes will be critically evaluated.

This track will delve into the role of molecular diagnostics in tailoring cancer therapies to individual patients. Discussions will include the integration of genomic data into clinical practice and its implications for treatment efficacy.

This session will address the unique challenges faced in the diagnosis and treatment of pediatric cancers. Participants will explore innovative approaches and recent advancements in this specialized field.

This track will focus on the latest findings in cancer epidemiology, emphasizing risk factors and prevention strategies. Discussions will include public health initiatives aimed at reducing cancer incidence.

This session will explore the role of interventional techniques in the management of cancer, including ablation and embolization. The effectiveness and safety of these procedures will be critically assessed.

This track will highlight advancements in radiation therapy, including stereotactic techniques and novel radiopharmaceuticals. Participants will discuss the implications of these innovations on treatment outcomes.

This session will examine the role of nursing in oncology care, focusing on integrative approaches to support patient well-being. Discussions will include the importance of holistic care in cancer treatment.

This track will focus on the latest research and treatment strategies for hematologic malignancies, including leukemia and lymphoma. Participants will discuss novel therapies and their impact on patient management.